Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/1999
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899339A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899337A2 FtsY polynucleotides and polypeptides of Stapyloccoccus aureus belonging to the signal recognition protein family
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899335A2 MurB gene from Staphylococcus aureus
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0898967A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
03/03/1999EP0898619A1 Chimeric cell-surface receptors that undergo antigen-induced association
03/03/1999EP0898580A1 Methods and means for inhibition of cdk4 activity
03/03/1999EP0898578A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
03/03/1999EP0898577A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
03/03/1999EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex
03/03/1999CN1209876A Isolated tyrosinase derived peptides and uses thereof
03/03/1999CN1209843A Noval method for characterization of compounds which stimulate STF-1 expression in pancreatic islet cells
03/03/1999CN1209548A Method for preparing carbide resin DNA immunity adsorbent
03/03/1999CN1209436A Human semaphorin L(H-SemaL) and corresponding semaphorins in other species
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877309 Nucleotide sequences which suppress expression of jun n-terminal kinase oncogene by complementary hybridization; antiproliferative agents, antitumor agents, anticarcinogenic agentsand antimetastasis agents
03/02/1999US5877308 Synthetic oligonucleotide that is complemtary to capl mrna including the 3' splice site thereby inhibiting capl gene expression; anticarcinogenic agents
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease
03/02/1999US5877283 Polypeptide for obesity and type II diabetes mellitus
03/02/1999US5877162 Short external guide sequences
03/02/1999US5877159 The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense rna or a catalytic rna.
03/02/1999US5877022 Ribozymes targeted to APO(a) RNA
03/02/1999US5877011 Chimeric adenoviral vectors
03/02/1999US5877010 Thymidine kinase mutants
03/02/1999US5876979 RNA component of mouse, rat, Chinese hamster and bovine telomerase
03/02/1999US5876974 Method for producing DNA encoding cystic fibrosis transmembrane conductance regulator (CFTR) protein in E. coli
03/02/1999US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876967 Fibroblast growth factor homologous factor-2 and methods of use
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876939 Screening for apoptosis modulators by determining alteration of association between cytoplasmic domain of cell surface protein and other proteins in presence of compound; anticarcinogenic agents
03/02/1999US5876931 Identification of genes
03/02/1999US5876923 Screening suppressors which inhibit infected cell protein-4 polypetide by infecting cells with defective alpha-4 gene virus, incubating with compound allowing viral replication, comparing cell pathology
03/02/1999US5876919 Incubating compound with tub protein in vitro, detection of complex formed; for modulators of obesity, cachexia, and other eating disorders
03/02/1999US5876735 Methods for enhancement of protective immune responses
03/02/1999US5876708 Allogeneic and xenogeneic transplantation
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241427A1 Novel pyrr homolog
02/28/1999CA2241424A1 Novel ftsy
02/28/1999CA2241400A1 Ftsy
02/27/1999CA2233681A1 Novel div1b
02/26/1999CA2241431A1 Novel spoiiie
02/26/1999CA2241410A1 Pth
02/25/1999WO1999009412A1 Functional fragments of hiv-1 vpr protein and methods of using the same
02/25/1999WO1999009214A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999WO1999009193A1 Coat-protein-modified baculovirus vector for gene therapy
02/25/1999WO1999009192A1 Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells
02/25/1999WO1999009191A1 Vectors for treating cancer
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009178A1 Functional characterization of the c-c chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2
02/25/1999WO1999009176A1 Neisseria lactoferrin binding protein
02/25/1999WO1999009167A1 Porcine mhc class i genes and uses thereof
02/25/1999WO1999009164A1 Coding sequence haplotypes of the human brca2 gene
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009161A1 Pancreas-derived plasminogen activator inhibitor
02/25/1999WO1999009156A2 Protease-related protein
02/25/1999WO1999009152A1 Human frezzled-like protein
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009139A1 Retrovirus and viral vectors
02/25/1999WO1999009063A1 Interleukin-18 binding proteins, their preparation and use
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999009045A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999WO1999009037A1 Phospholipid analogue compounds
02/25/1999WO1999008997A1 Novel lipopolyamines, and the preparation and use thereof
02/25/1999WO1999008713A1 Vaccination by topical application of genetic vectors
02/25/1999WO1999008712A2 METHOD FOR INFLUENCING THE p53 LINKAGE IN TARGET GENES
02/25/1999WO1999008711A1 Lipid-polyamide conjugates and compositions for nucleic acid delivery
02/25/1999WO1999008533A1 Central nervous system axon regeneration
02/25/1999WO1999008510A1 Atrial natriuretic factor mutants and ischemic stroke
02/25/1999WO1998051285A3 Cationic amphiphile formulations
02/25/1999WO1998049321A3 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
02/25/1999WO1998005678A3 Novel cationic amphiphilic lipids for liposomal gene transfer
02/25/1999DE19736592A1 New macrocyclic tetraether lipid derivatives
02/25/1999DE19735776A1 New neutral or cationic phospholipid analogues
02/25/1999CA2303201A1 Vectors for treating cancer
02/25/1999CA2301862A1 Atrial natriuretic factor mutants and ischemic stroke
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2301332A1 Neisseria lactoferrin binding protein
02/25/1999CA2301328A1 Vaccination by topical application of genetic vectors
02/25/1999CA2301295A1 Functional fragments of hiv-1 vpr protein and methods of using the same
02/25/1999CA2301169A1 Porcine mhc class i genes and uses thereof
02/25/1999CA2301139A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999CA2300957A1 Retrovirus and viral vectors
02/25/1999CA2300938A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999CA2300878A1 Central nervous system axon regeneration
02/25/1999CA2300390A1 Human frezzled-like protein
02/25/1999CA2300362A1 Coat-protein-modified baculovirus vector for gene therapy
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2300059A1 Method for influencing the p53 linkage in target genes
1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 870